We are live on ! Find out more
U

UBS Portfolio holdings

AUM $136B
1-Year Est. Return 16.36%
This Fund
S&P 500
This Quarter Est. Return
+1.89%
1 Year Est. Return
+16.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$113B
AUM Growth
+$5.56B
Cap. Flow
+$4.14B
Cap. Flow %
3.68%
Top 10 Hldgs %
14.26%
Holding
11,559
New
1,144
Increased
4,238
Reduced
4,557
Closed
1,117

Sector Composition

Rank Sector Weight
1 Energy 8.95%
2 Financials 7.03%
3 Technology 6.55%
4 Healthcare 6.54%
5 Industrials 5.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BERY
8651
PUT
DELISTED
Berry Global Group, Inc.
BERY
$12K ﹤0.01%
545
-16,661
-97% -$357K
B
8652
CALL
DELISTED
Barnes Group Inc.
B
$12K ﹤0.01%
300
-200
-40% -$7.62K
ERF
8653
PUT
DELISTED
Enerplus Corporation
ERF
$12K ﹤0.01%
604
-44,325
-99% -$829K
NXGN
8654
CALL
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$12K ﹤0.01%
700
+400
+133% +$7.25K
NXGN
8655
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$12K ﹤0.01%
688
-2,491
-78% -$45.2K
EMAN
8656
DELISTED
eMagin Corporation
EMAN
$12K ﹤0.01%
4,700
-2,104
-31% -$5.77K
NUVA
8657
CALL
DELISTED
NuVasive, Inc.
NUVA
$12K ﹤0.01%
+300
New +$11K
ISEE
8658
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$12K ﹤0.01%
349
-1,038
-75% -$35K
ZVO
8659
PUT
DELISTED
Zovio Inc. Common Stock
ZVO
$12K ﹤0.01%
800
-800
-50% -$13.8K
LUB
8660
DELISTED
Luby's Inc.
LUB
$12K ﹤0.01%
2,000
+1,465
+274% +$9.59K
OCSI
8661
DELISTED
Oaktree Strategic Income Corporation
OCSI
$12K ﹤0.01%
800
-3,562
-82% -$49.5K
TTPH
8662
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$12K ﹤0.01%
54
+51
+1,700% +$14.2K
TYPE
8663
DELISTED
Monotype Imaging Holdings Inc.
TYPE
$12K ﹤0.01%
400
-1,980
-83% -$59.5K
PNTR
8664
DELISTED
Pointer Telocation Ltd.
PNTR
$12K ﹤0.01%
+1,190
New +$12.1K
HGT
8665
PUT
DELISTED
Hugoton Royalty Trust
HGT
$12K ﹤0.01%
1,500
-100
-6% -$832
WGL
8666
CALL
DELISTED
Wgl Holdings
WGL
$12K ﹤0.01%
+300
New +$11.6K
LEDD
8667
DELISTED
iPath Pure Beta Lead ETN
LEDD
$12K ﹤0.01%
+319
New +$12.1K
CASC
8668
CALL
DELISTED
Cascadian Therapeutics, Inc.
CASC
$12K ﹤0.01%
650
-32,050
-98% -$526K
BV
8669
CALL
DELISTED
Bazaarvoice, Inc.
BV
$12K ﹤0.01%
1,600
+1,000
+167% +$7.56K
GIMO
8670
DELISTED
Gigamon Inc.
GIMO
$12K ﹤0.01%
400
-2,110
-84% -$66.4K
RNVA
8671
DELISTED
Rennova Health, Inc.
RNVA
$12K ﹤0.01%
+1
New +$15.8K
PPP
8672
CALL
DELISTED
Primero Mining Corp
PPP
$12K ﹤0.01%
+1,600
New +$9.87K
EVER
8673
CALL
DELISTED
Everbank Financial Corp
EVER
$12K ﹤0.01%
600
SQNM
8674
PUT
DELISTED
SEQUENOM INC NEW
SQNM
$12K ﹤0.01%
4,900
+1,000
+26% +$2.38K
FNFG
8675
PUT
DELISTED
FIRST NIAGARA FINANCIAL GROUP INC
FNFG
$12K ﹤0.01%
1,300
-800
-38% -$7.42K

Similar funds

UBS's Q1 2014 Portfolio in Review

As of Q1 2014, UBS held 11,559 positions worth $113B, up 5.2% from $107B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS deployed $4.14B of net new capital in Q1 2014, opening 1,144 new positions and adding to 4,238 existing holdings. Its largest new stake was iShares MSCI USA Quality Factor ETF: 336,642 shares worth $19M.

By sector, the portfolio is most concentrated in Energy at 9% of assets, up from 8.5% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Herc Holdings, an estimated $419M trimmed.

  • UBS's largest Q1 2014 buy was iShares MSCI USA Quality Factor ETF: 336,642 shares worth $19M.
  • UBS added most to State Street SPDR S&P 500 ETF Trust in Q1 2014, an estimated $1.61B increase.
  • UBS's biggest Q1 2014 reduction was Herc Holdings, cutting an estimated $419M.
  • UBS fully exited COLE REAL ESTATE INVESTMENTS, INC COM in Q1 2014, selling an estimated $233M.
  • UBS's ten largest holdings make up 14% of its $113B portfolio in Q1 2014.
  • UBS opened 1,144 new positions and closed 1,117 in Q1 2014.
  • UBS's portfolio value rose 5.2% quarter-over-quarter to $113B.

Based on UBS's 13F filing for Q1 2014, filed 15 May 2014.